Should patients with 'borderline' lesions of Banff criteria be treated by renal transplantation?

Transplantation Proceedings

Volumn 30, Issue 6, 1998, Pages 2823-2824

  Lorriaux, C ^a   Mac Gregor, B ^b   Dijoud, F ^b   Cahen, R ^b   Touraine, J L ^b   Pouteil Nobel, C ^b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HLA ANTIGEN; METHYLPREDNISOLONE;

CONFERENCE PAPER; GRAFT SURVIVAL; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BIOPSY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; METHYLPREDNISOLONE; REOPERATION; RETROSPECTIVE STUDIES;

EID: 0031679656     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00826-4     Document Type: Conference Paper

References (6)

1. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, et al: Kidney Int 44:41, 1993
2. Colvin RB: Kidney Int 50:1069, 1996
3. Bogman MJJT, Dooper PMM: Nephrol Dial Transplant, 1291, 1995
4. Dooper PMM, Hoitsma AJ, Koene RAP, Bogman MJJT: Transplant Proc 2:1005, 1995
5. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Gough J: Transplantation 57:208, 1994
6. Rush DN, Jeffery JR, Gough J: Transplantation 4:511, 1995